Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Development of a FibroScan Liver Examination Using a Single Probe

NCT: NCT07400289 · RECRUITING

NCT IDNCT07400289
StatusRECRUITING
Start Date2025-11-14
Completion2027-05-31
SponsorEchosens (INDUSTRY)
First posted
Last updated

Brief Summary

This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).

Frequently Asked Questions

What is Development of a FibroScan Liver Examination Using a Single Probe?

Development of a FibroScan Liver Examination Using a Single Probe is a clinical trial registered under NCT07400289. Current status: RECRUITING.

What is the status of NCT07400289?

The current status of NCT07400289 (Development of a FibroScan Liver Examination Using a Single Probe) is: RECRUITING.

When did Development of a FibroScan Liver Examination Using a Single Probe start?

Development of a FibroScan Liver Examination Using a Single Probe started on 2025-11-14.

Related Devices

K160524FibroScan 530 CompactEchosens K172142FibroScan 430 Mini+Echosens K173034FibroScan® Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+)Echosens K181547FibroScan® Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+)Echosens K200655FibroScan® 630Echosens

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑